We are live on ! Find out more
DS

David Shaw D.E. Shaw & Co

AUM $210B
1-Year Est. Return 57.28%
 

David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.

This Fund
S&P 500
This Quarter Est. Return
+6.67%
1 Year Est. Return
+57.28%
3 Year Est. Return
+174.63%
5 Year Est. Return
+213.1%
10 Year Est. Return
+910%
AUM
$76.7B
AUM Growth
+$3.2B
Cap. Flow
-$965M
Cap. Flow %
-1.26%
Top 10 Hldgs %
9.81%
Holding
4,066
New
622
Increased
1,512
Reduced
1,263
Closed
399

Sector Composition

Rank Sector Weight
1 Technology 15.15%
2 Consumer Discretionary 12.62%
3 Healthcare 10.65%
4 Financials 9.26%
5 Industrials 6.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RNR icon
2651
RenaissanceRe
RNR
$13.6B
$1.01M ﹤0.01%
8,404
-249,412
-97% -$32.2M
DISH
2652
CALL
DELISTED
DISH Network Corp.
DISH
$1.01M ﹤0.01%
30,000
EVBG
2653
DELISTED
Everbridge, Inc. Common Stock
EVBG
$1.01M ﹤0.01%
+21,213
New +$903K
AGX icon
2654
Argan
AGX
$6.32B
$1M ﹤0.01%
24,551
+18,564
+310% +$724K
SYF icon
2655
PUT
Synchrony
SYF
$26.2B
$1M ﹤0.01%
30,000
MIC
2656
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
$1M ﹤0.01%
+23,732
New +$932K
PAHC icon
2657
Phibro Animal Health
PAHC
$1.45B
$1M ﹤0.01%
21,713
-11,051
-34% -$489K
SNA icon
2658
Snap-on
SNA
$20.4B
$998K ﹤0.01%
6,206
+481
+8% +$72.8K
AXDX
2659
DELISTED
Accelerate Diagnostics
AXDX
$996K ﹤0.01%
4,465
-1,533
-26% -$343K
CNCE
2660
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$994K ﹤0.01%
59,063
+12,196
+26% +$237K
UBA
2661
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
$993K ﹤0.01%
43,912
-7,467
-15% -$156K
HMY icon
2662
Harmony Gold Mining
HMY
$14.3B
$992K ﹤0.01%
636,212
+164,715
+35% +$308K
LDOS icon
2663
CALL
Leidos
LDOS
$17B
$991K ﹤0.01%
16,800
VSI
2664
DELISTED
Vitamin Shoppe Inc.
VSI
$991K ﹤0.01%
142,563
+25,774
+22% +$141K
AWK icon
2665
American Water Works
AWK
$27.4B
$990K ﹤0.01%
11,599
+8,921
+333% +$738K
SSRM icon
2666
CALL
SSR Mining
SSRM
$8.01B
$987K ﹤0.01%
100,000
CYTK icon
2667
Cytokinetics
CYTK
$10.9B
$986K ﹤0.01%
118,751
+15,393
+15% +$128K
OMF icon
2668
OneMain Financial
OMF
$7.25B
$984K ﹤0.01%
29,560
+11,373
+63% +$368K
NBIX icon
2669
CALL
Neurocrine Biosciences
NBIX
$15.5B
$982K ﹤0.01%
+10,000
New +$895K
NBIX icon
2670
PUT
Neurocrine Biosciences
NBIX
$15.5B
$982K ﹤0.01%
10,000
DATA
2671
CALL
DELISTED
Tableau Software, Inc.
DATA
$978K ﹤0.01%
10,000
FIVE icon
2672
CALL
Five Below
FIVE
$14.2B
$977K ﹤0.01%
10,000
MRT
2673
DELISTED
MedEquities Realty Trust, Inc.
MRT
$977K ﹤0.01%
88,661
+14,629
+20% +$151K
THO icon
2674
CALL
Thor Industries
THO
$4.13B
$974K ﹤0.01%
+10,000
New +$1.02M
ATRO icon
2675
Astronics
ATRO
$3.22B
$973K ﹤0.01%
37,341
-6,485
-15% -$172K

Similar funds

David Shaw's Q2 2018 Portfolio in Review

As of Q2 2018, David Shaw held 4,066 positions worth $76.7B, up 4.4% from $73.5B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.

David Shaw's Q2 2018 filing shows 622 new, 1,512 increased, 1,263 reduced and 399 closed positions. Its largest new stake was Evergy: 4,161,679 shares worth $234M. The largest sale was Time Warner Inc, an estimated $648M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • David Shaw's largest Q2 2018 buy was Evergy: 4,161,679 shares worth $234M.
  • David Shaw added most to Amazon in Q2 2018, an estimated $696M increase.
  • David Shaw's biggest Q2 2018 reduction was Merck, cutting an estimated $453M.
  • David Shaw fully exited Time Warner Inc in Q2 2018, selling an estimated $648M.
  • David Shaw's ten largest holdings make up 9.8% of its $76.7B portfolio in Q2 2018.
  • David Shaw opened 622 new positions and closed 399 in Q2 2018.
  • David Shaw's portfolio value rose 4.4% quarter-over-quarter to $76.7B.

Based on D.E. Shaw & Co's 13F filing for Q2 2018, filed 14 Aug 2018.